Introducing Express Results™ Online

by Nicole Jupe on February 23, 2015

express-results-online-at-laptopDo you need to quickly determine if a job candidate is drug-free? Do you want a test panel that screens for a variety of commonly-used drugs? Would you prefer to let a trained collector administer the drug test?

Quest Diagnostics now offers Express Results Online, an instant, urine drug testing solution designed to deliver fast, dependable results - we understand time is critical. The Express Results Online testing process is designed to consistently deliver both speed and accuracy.

The entire drug testing process is completed online – from order to result. Negative results are available within minutes from the time of collection and the instant test device can screen for up to 11 different drugs. Express Results Online screens for amphetamine, barbiturates, benzodiazepines, cocaine, marijuana, methadone, methamphetamine, opiates, oxycodone, PCP and propoxyphene. You are able to select which drugs to include in your panel.

Our nationwide collection site network offers convenient drug testing locations staffed with trained collectors. Every collector follows a standardized protocol that helps to ensure a flawless collection experience every time.

Express Results Online helps you to easily manage the drug testing process electronically with remarkable speed. With one solution, you can:

  • Screen for up to 11 drugs
  • Get accurate results within minutes
  • Simplify the drug test collection experience
  • Available for non-regulated drug testing programs

For more information, download our Express Results Online brochure or contact us online.

Fortune Most AdmiredQuest Diagnostics is once again recognized by Fortune Magazine as one of the world’s most admired healthcare companies in 2015. With high marks for Innovation and global competitiveness, Quest stands out as the only diagnostic information services company to make the list.

The Most Admired companies list is the result of a robust survey where 668 companies from 29 countries are evaluated. Admiration is measured through ratings of criteria ranging from investment value to social responsibility. The survey results are widely recognized as the definitive report card on corporate reputations.

President and CEO Steve Rusckowski acknowledged the collective team effort it takes to earn this kind of accolade, “The Most Admired designation is a true team accomplishment, and my thanks and appreciation go to the 45,000 employees who empower better health care every day for the people we serve.”

To learn more about Quest Diagnostics visit our website or contact us online.

Name that Drug: Lifting the Veil on Drugs in Disguise

February 18, 2015 Industry News

DATIA focus is the quarterly publication of the Drug & Alcohol Testing Industry Association (DATIA). DATIA focus features a regular, popular column titled, “Name that Drug” where interesting facts about a mystery drug are described in advance of the name being revealed. The latest edition of “Name that Drug” was written by Dr. Kimberly Samano, […]

Read the full article →

Winter Storm Octavia

February 17, 2015 Industry News

Mother Nature brings ice to Kentucky, Tennessee, North Carolina, South Carolina and Virginia with states of emergency declared. Nashville’s ice storm shut down the city with its mayor advising against travel. FedEx has reported disruptions and delays at its Memphis hub and for the midsouth and northeast regions of the U.S. The storm has put thousands of […]

Read the full article →

More Synthetic Cannabinoids Elevated to Schedule I Ban

February 13, 2015 Industry News

Responsible for a 40% increase in emergency room visits from 2010 to 2011, synthetic cannabinoids have reached a heightened level of notoriety. Some of the reported symptoms during these ER visits were severe vomiting, hallucinations and, in some cases, cardiac arrest. Banned in several countries since 2004, synthetic cannabinoids (also commonly known as K2, spice […]

Read the full article →

Detect Repetitive Drug Use with Hair Testing

February 12, 2015 Hair Testing

Workplace health and safety is more important than ever with an increase of workplace injuries, accidents and workers’ compensation claims. According to the National Survey on Drug Use and Health, 75 percent of drug users are employed, and the U.S. Department of Labor reports drug abuse causes 65 percent of on-the-job accidents. As these numbers […]

Read the full article →

Dissecting the Data

February 11, 2015 Industry News

Many sources of data exist for examining drug use trends. Yet, according to a new article in the winter issue of DATIA Focus magazine, “There is no single data source that can answer all of the questions pertaining to drug use trends in the U.S.” Dr. Barry Sample, Director of Science and Technology, Quest Diagnostics, pours […]

Read the full article →

Winter Storm Juno Arrives

January 27, 2015 Industry News

Due to Winter Storm Juno, Quest Diagnostics Patient Service Centers (PSCs) in New York, New Jersey and New England will not open on Tuesday, January 27, 2015. Weather reports say the storm “is pounding New England with heavy snow, coastal flooding and wind gusts.”  Blizzard warnings are in effect for 6 states and New York City […]

Read the full article →

Preparing for Winter Storm Juno

January 26, 2015 Industry News

The Northeast is bracing for Winter Storm Juno which is forecasted to bring high snowfall amounts and blizzard conditions from today until Wednesday, January 28. Quest Diagnostics Patient Service Centers (PSCs) and laboratories in the region may adjust their hours of operation as we encourage our patients, donors and employees to remain safe. Our drug […]

Read the full article →

Report Examines Marijuana’s Impact in Colorado and Washington

January 7, 2015 Industry News

Recreational marijuana use has increased in all age groups in the states where it is legal according to a new report released by Smart Approaches to Marijuana (SAM) called Lessons After Two Years of Legalization. The report reviews the available data “to accurately evaluate the consequences and costs of marijuana legalization in Washington and Colorado.” […]

Read the full article →